Lotte Biologics

Activity by year

2023202420252026

AcquisitionNew facility

Jan 11, 2023NEW FACILITYSouth Korea, South Korea$3.00Bops 2027
Lotte Biologics to invest $3B to build three plants in South Korea
Lotte Biologics will invest $3 billion to build a bio industrial complex with three plants in South Korea by 2030, with annual capacity of 360,000 liters of antibody drugs. The first plant is scheduled for commercial production from 2027.
Lotte Biologics #Medical Devices pulse.mk.co.kr
Jan 1, 2023ACQUISITIONSyracuse, New York, United States$160.0M
Lotte Biologics completes acquisition of Bristol Myers Squibb plant in Syracuse
Lotte Biologics completed the acquisition of a plant from Bristol Myers Squibb in Syracuse, New York for $160 million on January 1, 2023, to develop it as its North American center.
Lotte Biologics acquirer Bristol Myers Squibb target #Medical Devices pulse.mk.co.kr

Site	Largest	Latest
South Korea, South Korea	$3.00B	2023-01-11

Acquired

Loading…